Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: Possible involvement in excessive interferon-γ and anti-double-stranded DNA antibody production

Arthritis Research and Therapy

Volumn 8, Issue 3, 2006, Pages

  Kawamoto, Manabu ^a   Harigai, Masayoshi ^a,b   Hara, Masako ^a   Kawaguchi, Yasushi ^a   Tezuka, Katsunari ^c   Tanaka, Michi ^a   Sugiura, Tomoko ^a   Katsumata, Yasuhiro ^a   Fukasawa, Chikako ^a   Ichida, Hisae ^a   Higami, Satomi ^a   Kamatani, Naoyuki ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c JAPAN TOBACCO INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYTOKINE; DNA; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MONOCLONAL ANTIBODY;

B LYMPHOCYTE; BLOOD; COCULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; PHYSIOLOGY; REFERENCE VALUE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; B-LYMPHOCYTES; COCULTURE TECHNIQUES; CYTOKINES; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MALE; REFERENCE VALUES; T-LYMPHOCYTES;

EID: 34247551065     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar1928     Document Type: Article

References (48)

1. Hahn BH: An overview of the pathogenesis of systemic lupus erythematosus. In Dubois' Lupus Erythematosus Edited by: Wallace DJ, Hahn BH. Baltimore, MA: Williams & Wilkins; 1997:69-76.
2. Rekvig OP, Nossent JC: Anti-double-stranded DNA antibodies, nucleoses, and systemic lupus erythematosus: A time for new paradigms Arthritis Rheum 2003, 48:300-312.
3. + T cells. Immunol Rev 1998, 165:231-247.
4. Watts TH, DeBendette MA: T cell co-stimulatory molecules other than CD28. Curr Opin Immunol 1999, 11:286-293.
5. Carreno BM, Collins M: The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 2002, 20:29-53.
6. Sharpe AH, Freeman GJ: The B7-CD28 superfamily. Nat Rev Immunol 2002, 2:116-126.
7. Croft M: Co-stimulatory members of thK TNFR family: keys to effective T-cell immunity? Nat Rev Immunol 2003, 3:609-620.
8. Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R, Anagnostopoulos I, Kroczek RA: ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 1999, 397:263-266.
9. Yoshinaga SK, Whoriskey JS, Khare SD, Sarmiento U, Guo J, Horan T, Shih G, Zhang M, Coccia MA, Kohno T, et al.: T-cell costimulation through B7RP-1 and ICOS. Nature 1999, 402:827-832.
10. Tezuka K, Tsuji T, Hirano D, Tamatani T, Sakamaki K, Kobayashi Y, Kamada M: Identification and characterization of rat AILIM/ICOS, a novel T-cell costimulatory molecule, related to the CD28/CTLA4 family. Biochem Biophys Res Commun 2000, 276:335-345.
11. Riley JL, Blair PJ, Musser JT, Abe R, Tezuka K, Tsuji T, June CH: ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement. J Immunol 2001, 166:4943-4948.
12. + T cells. J Immunol 2000, 165:5035-5040.
13. Yoshinaga SK, Zhang M, Pistillo J, Horan T, Khare SD, Miner K, Sonnenberg M, Boone T, Brankow D, Dai T, et al.: Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS. Int Immunol 2000, 12 1439-1447.
14. Ling V, Wu PW, Finnerty HF, Bean KM, Spaulding V, Fouser LA, Leonard JP, Hunter SE, Zollner R, Thomas JL, et al.: Cutting edge: identification of GL50, a novel B7-like protein that functional binds to ICOS receptor. J Immunol 2000, 164:1653-1657.
15. Wang S, Zhu G, Chapoval AI, Dong H, Tamada K, Ni J, Chen L: Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS Blood 2000, 96:2808-2813.
16. Aicher A, Hayden-Ledbetter M, Brady WA, Pezzutto A, Richter G, Magaletti D, Buckwalter S, Ledbetter JA, Clark EA: Characterization of human inducible costimulator ligand expression and function. J Immunol 2000, 164:4689-4696.
17. Ling V, Wu PW, Miyashiro JS, Marusic S, Finnerty HF, Collins M: Differential expression of inducible costimulator-ligand splice variants: Lymphoid regulation of mouse GL50-B and human GL50 molecules J Immunol 2001, 166:7300-7308.
18. Guo J, Stolina M, Bready JV, Yin S, Horan T, Yoshinaga SK, Senaldi G: Stimulatory effects of B7-related protein-1 on cellular and humoral immune responses in mice. J Immunol 2001, 166:5578-5584.
19. Dong C, Juedes AE, Temann UA, Shresta S, Allison JP, Ruddle NH, Flavell RA: ICOS co-stimulatory receptor is essential for Tcell activation and function. Nature 2001, 409:97-101.
20. Tafuri A, Shahinian A, Bladt F, Yoshinaga SK, Jordana M, Wakeham A, Boucher LM, Bouchard D, Chan VS, Duncan G, et al.: ICOS is essential for effective T-helper-cell responses. Nature 2001, 409:105-109.
21. Smith KM, Brewer JM, Webb P, Coyle AJ, Gutierrez-Ramos C, Garside P: Inducible costimulatory molecule-B7-related protein 1 interactions are important for the clonal expansion and B cell helper functions of naive, Th1, and Th2 T cells. J Immunol 2003, 170:2310-2315.
22. Iwai H, Abe M, Hirose S, Tsushima F, Tezuka K, Akiba H, Yagita H, Okumura K, Kohsaka H, Miyasaka N, et al.: Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritis. J Immunol 2003, 171:2848-2854.
23. Iwai H, Kozono Y, Hirose S, Akiba H, Yagita H, Okumura K, Kohsaka H, Miyasaka N, Azuma M: Amelioration of collagen-induced arthritis by blockade of inducible costimulator-B7 homologous protein costimulation J Immunol 2002, 169:4332-4339.
24. Nurieva RI, Treuting P, Duong J, Flavell RA, Dong C: Inducible costimulator is essential for collagen-induced arthritis. J Clin Invest 2003, 111:701-706.
25. Rottman JB, Smith T, Tonra JR, Ganley K, Bloom T, Silva R, Pierce B, Gutierrez-Ramos JC, Ozkaynak E, Coyle AJ: The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE. Nat Immunol 2001, 2:605-611.
26. Sporici RA, Beswick RL, von Allmen C, Rumbley CA, Hayden-Ledbetter M, Ledbetter JA, Perrin PJ: ICOS ligand costimulation is required for T-cell encephalitogenicity. Clin Immunol 2001, 100 277-288.
27. Akbari O, Freeman GJ, Meyer EH, Greenfield EA, Chang TT, Sharpe AH, Berry G, DeKruyff RH, Umetsu DT: Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 2002, 8:1024-1032.
28. Wiley RE, Goncharova S, Shea T, Johnson JR, Coyle AJ, Jordana M: Evaluation of inducible costimulator/B7-related protein-1 as a therapeutic target in a murine model of allergic airway inflammation. Am J Respir Cell Mol Biol 2003, 28:722-730.
29. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277.
30. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH: Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992, 35:630-640.
31. Mendez MJ, Green LL, Corvalan JR, Jia XC, Maynard-Currie CE, Yang XD, Gallo ML, Louie DM, Lee DV, Erickson KL, et al.: Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice. Nat Genet 1997, 15:146-156.
32. Sakamoto I, Tezuka K, Tsuji T, Hori N, Tamatani T: AILIM/ICOS: its expression and functional analysis with monoclonal antibodies. Hybrid Hybridomics 2001, 20:293-303.
33. Harigai M, Hara M, Fukasawa C, Nakazawa S, Kawaguchi Y, Kamatani N, Kashiwazaki S: Responsiveness of peripheral blood B cells to recombinant CD40 ligand in patients with systemic lupus erythematosus Lupus 1999, 8:227-233.
34. Pollard KM, Hultman P, Kono DH: Using single-gene deletions to identify checkpoints in the progression of systemic autoimmunity. Ann N Y Acad Sci 2003, 987:236-239.
35. Theofilopoulos AN, Koundouris S, Kono DH, Lawson BR: The role of IFN-gamma in systemic lupus erythematosus: A challenge to the Th1/Th2 paradigm in autoimmunity. Arthritis Res 2001, 3:136-141.
36. Uhm WS, Na K, Song GW, Jung SS, Lee T, Park MH, Yoo DH: Cytokine balance in kidney tissue from lupus nephritis patients. Rheumatology (Oxford) 2003, 42:935-938.
37. Miyake K, Nakashima H, Akahoshi M, Inoue Y, Nagano S, Tanaka Y, Masutani K, Hirakata H, Gondo H, Otsuka T, Harada M: Genetically determined interferon-gamma production influences the histological phenotype of lupus nephritis. Rheumatology (Oxford) 2002, 41:518-524.
38. Masutani K, Akahoshi M, Tsuruya K, Tokumoto M, Ninomiya T, Kohsaka T, Fukuda K, Kanai H, Nakashima H, Otsuka T, Hirakata M: Predominance of Th1 immune response in diffuse proliferative lupus nephritis. Arthritis Rheum 2001, 44:2097-2106.
39. Akahoshi M, Nakashima H, Tanaka Y, Kohsaka T, Nagano S, Ohgami E, Arinobu Y, Yamaoka K, Niiro H, Shinozaki M, et al.: Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum 1999, 42:1644-1648.
40. Yokoyama H, Takabatake T, Takaeda M, Wada T, Naito T, Ikeda K, Goshima S, Takasawa K, Tomosugi N, Kobayashi K, et al.: Up-regulated MHC-class II expression and gamma-IFN and soluble IL-2R in lupus nephritis. Kidney Int 1992, 42:755-763.
41. + effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10. J Exp Med 2003, 197:181-193.
42. Riley JL, Blair PJ, Musser JT, Abe R, Tezuka K, Tsuji T, June CH: ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement. J Immunol 2001, 166:4943-4948.
43. + T cells. Proc Natl Acad Sci USA 2002, 99:6198-6203.
44. Beier KC, Hutloff A, Dittrich AM, Heuck C, Rauch A, Buchner K, Ludewig B, Ochs HD, Mages HW, Kroczek RA: Induction, binding specificity and function of human ICOS. Eur J Immunol 2000, 30:3707-3717.
45. Hutloff A, Buchner K, Reiter K, Baelde HJ, Odendahl M, Jacobi A, Dorner T, Kroczek RA: Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus. Arthritis Rheum 2004, 50:3211-3220.
46. Lawson BR, Prud'homme GJ, Chang Y, Gardner HA, Kuan J, Kono DH, Theofilopoulos AN: Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc. J Clin Invest 2000, 106:207-215.
47. Wong SC, Oh E, Ng CH, Lam KP: Impaired germinal center formation and recall T-cell-dependent immune responses in mice lacking the costimulatory ligand B7-H2. Blood 2003, 102:1381-1388.
48. Vinuesa CG, Cook MC, Angelucci C, Athanasopoulos V, Rui L, Hill KM, Yu D, Domaschenz H, Whittle B, Lambe T, et al.: A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 2005, 435:452-458.